m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00723)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
HSD17B11
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Fat mass and obesity-associated protein (FTO) [ERASER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | FTO relys on the reading protein YTHDF1 to affect the translation pathway of the Estradiol 17-beta-dehydrogenase 11 (HSD17B11) gene to regulate the formation of lipid droplets in esophageal cancer cells. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Esophageal cancer | ICD-11: 2B70 | ||
Cell Process | Lipid metabolism | |||
In-vitro Model | TE-1 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1759 |
KYSE-510 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1354 | |
In-vivo Model | Nude mice were randomly divided into five groups of six mice each, and the mice in each group were received subcutaneous injections of shFTO, scrambled shNC, FTO OE, and vector KYSE510 cells (5×106 tumor cells/mouse), respectively. The tumor size and weight of mice were measured 1 week later, which was recorded as day 0, and then measured once every other day; and the tumor volumes were calculated using the following formula: (length×width2)/2.When the tumor maximum diameter was close to 15 mm, the mice were euthanized and the tumor tissues were collected for immunohistochemistry analysis. | |||
Esophageal cancer [ICD-11: 2B70]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | FTO relys on the reading protein YTHDF1 to affect the translation pathway of the Estradiol 17-beta-dehydrogenase 11 (HSD17B11) gene to regulate the formation of lipid droplets in esophageal cancer cells. | |||
Responsed Disease | Esophageal cancer [ICD-11: 2B70] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Lipid metabolism | |||
In-vitro Model | TE-1 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1759 |
KYSE-510 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1354 | |
In-vivo Model | Nude mice were randomly divided into five groups of six mice each, and the mice in each group were received subcutaneous injections of shFTO, scrambled shNC, FTO OE, and vector KYSE510 cells (5×106 tumor cells/mouse), respectively. The tumor size and weight of mice were measured 1 week later, which was recorded as day 0, and then measured once every other day; and the tumor volumes were calculated using the following formula: (length×width2)/2.When the tumor maximum diameter was close to 15 mm, the mice were euthanized and the tumor tissues were collected for immunohistochemistry analysis. | |||